Medicinal Products

EPIPEN 03 mg / 03 mL Injectable pack of 1 pen pre-filled with 030 mL

Generic drug of the therapeutic class: Allergology
Active ingredients: [AdrÚnaline, 4523], [AdrÚnaline, 4523], [AdrÚnaline, 4523]
laboratory: Meda Pharma

Injectable solution
All forms

Indication

EPIPEN (adrenaline) auto-injectors are indicated in the emergency treatment of severe allergic reactions (anaphylactic shock) caused by e.g. insect bites, foods, medicines or other allergens, as well as in the treatment of idiopathic or exercise-induced anaphylactic shock.

EPIPEN auto-injectors are intended for immediate administration in patients who have a risk of severe allergic reaction, including those with anaphylactic reaction history.

Dosage EPIPEN 03 mg / 03 mL Injectable pack of 1 pen pre-filled with 030 mL

EPIPEN (adrenaline) auto-injectors are indicated in the emergency treatment of severe allergic reactions (anaphylactic shock) caused by e.g. insect bites, foods, medicines or other allergens, as well as in the treatment of idiopathic or exercise-induced anaphylactic shock.

EPIPEN auto-injectors are intended for immediate administration in patients who have a risk of severe allergic reaction, including those with anaphylactic reaction history.

Against indications

There is no known absolute contraindication to the use of EPIPEN in an allergic emergency.

Epipen side effects

Undesirable effects associated with adreneral activation of alpha and beta receptors may include symptoms such as tachycardia and hypertension, as well as undesirable effects on the central nervous system.

The frequency of undesirable effects is evaluated in the following way: very common (≥ 1/10), frequent (≥ 1/100 to <1/10), not very frequent (≥ 1/1000 to <1/100), rare (≥ 1/10 000 to <1/1000), very rare (<1 / 10, 000), unknown (can not be estimated from the available data).

Classes of organ systems

FrÚquence

Undesirable effect

Psychiatric disorders

unknown

AnxiÚtÚ

Nervous System Affections

unknown

Headache, dizziness, tremors

Heart conditions

Rare

Stress cardiomyopathy

unknown

Tachycardia, cardiac arrhythmia

Vascular disorders

unknown

Hypertension, peripheral ischemia after accidental injection into the hands or feet

Gastrointestinal disorders

unknown

Nausea, vomiting

Skin and subcutaneous tissue disorders

unknown

Hyperhidrosis

General disorders and administration site abnormalities

unknown

AsthÚnie

Declaration of suspected undesirable effects

The declaration of undesirable effects suspected after authorization of the drug is important. It allows continuous monitoring of the beneficial / risk ratio of the drug. Health professionals declare any undesirable effects suspected via the national system of declaration: National Agency for the Safety of Medicines and Health Products (Ansm) and Network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr

Popular Posts

Category Medicinal Products, Next Article